Glucocorticoid therapy

Glucocorticoid therapy

Treatment using corticoids that are anti-inflammatory and immunosuppressive.
Mentioned in: Myelofibrosis
References in periodicals archive ?
8,9] In these patients, glucocorticoid therapy can rapidly lead to infectious complications, mainly with opportunistic pathogens.
These observations support the role of appropriately timed exogenous glucocorticoid therapy to replenish the deficient cortisol and provide a balance between the pathological circadian mismatch between cytokine and glucocorticoid production5.
Study results showed that, in patients receiving continuing glucocorticoid therapy, Prolia treatment led to greater gains in BMD, compared with risedronate, both at the lumbar spine (4.
Glucocorticoid therapy is not recommended for euthyroid, Ab +ve women undergoing ART
Glucocorticoid therapy was administered to relieve his symptoms.
Researchers say this is the first such study of its kind to specifically assess adverse effects of glucocorticoid therapy, even though it has been widely used in early RA.
Every current guideline and consensus statement regarding systemic glucocorticoid therapy in rheumatoid arthritis fall short of offering clinicians practical, evidence-based guidance, according to a systematic review of all 15 such documents published in 2011-2015 in English, French, German, and Spanish.
Treatment with systemic glucocorticoids is the current standard of care to achieve control of the disease, and nonsteroidal immunomodulatory agents such as azathioprine, mycophenolate mofetil, and dapsone can be used in conjunction to help reduce adverse effects associated with long-term glucocorticoid therapy.
The data indicated that treatment with Prolia for 12 months, compared to risedronate, led to significantly greater gains in bone mineral density at the lumbar spine and total hip, both in patients receiving continuing glucocorticoid therapy and in patients newly initiating glucocorticoid therapy.
The data showed that treatment with Prolia for 12 months, compared to risedronate, led to significantly greater gains in bone mineral density (BMD) at the lumbar spine and total hip, both in patients receiving continuing glucocorticoid therapy and in patients newly initiating glucocorticoid therapy.
Note: When a dog has a concurrent bacterial skin infection, oral glucocorticoid therapy is not recommended prior to treating the infection).
titled clinical profile of children with nephrotic syndrome not on glucocorticoid therapy concluded that infection is widely prevalent among that urinary tract infection (22.

Full browser ?